Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1867015201579073536 |
|---|---|
| author | Jay S. Raval Marian A. Rollins‐Raval Yara A. Park |
| author_facet | Jay S. Raval Marian A. Rollins‐Raval Yara A. Park Jay S. Raval Marian A. Rollins‐Raval Yara A. Park |
| collection | Wiley Open Access |
| contents | Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy Jay S. Raval Marian A. Rollins‐Raval Yara A. Park Journal of Clinical Apheresis ABSTRACT The practice of selecting replacement fluid for therapeutic plasma exchange (TPE) after percutaneous kidney biopsy is variable and often depends on the number of days after biopsy that the apheresis treatment plan is initiated. It has been previously reported that most centers utilize plasma for at least part of replacement fluid for TPE after kidney biopsy, and quite often for many days. In this retrospective study, 100 consecutive patients who underwent percutaneous kidney biopsy and had TPE initiated 2 days after biopsy were analyzed. Half of these patients had exclusively albumin replacement fluid, and the other half had replacement fluid with both albumin and plasma. Rates for bleeding at the kidney biopsy site were identical and occurred in 1 patient (2%) in each cohort. Future studies assessing bleeding risk in this patient population receiving TPE should concentrate on the duration within 1 day after percutaneous kidney biopsy. 10.1002/jca.70122 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| doi_str_mv | 10.1002/jca.70122 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_jca_70122 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| publishDate | 2026 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy Jay S. Raval Marian A. Rollins‐Raval Yara A. Park Journal of Clinical Apheresis Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy Jay S. Raval Marian A. Rollins‐Raval Yara A. Park Journal of Clinical Apheresis ABSTRACT The practice of selecting replacement fluid for therapeutic plasma exchange (TPE) after percutaneous kidney biopsy is variable and often depends on the number of days after biopsy that the apheresis treatment plan is initiated. It has been previously reported that most centers utilize plasma for at least part of replacement fluid for TPE after kidney biopsy, and quite often for many days. In this retrospective study, 100 consecutive patients who underwent percutaneous kidney biopsy and had TPE initiated 2 days after biopsy were analyzed. Half of these patients had exclusively albumin replacement fluid, and the other half had replacement fluid with both albumin and plasma. Rates for bleeding at the kidney biopsy site were identical and occurred in 1 patient (2%) in each cohort. Future studies assessing bleeding risk in this patient population receiving TPE should concentrate on the duration within 1 day after percutaneous kidney biopsy. 10.1002/jca.70122 http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| title | Bleeding Risk Is Not Increased When Initiating Therapeutic Plasma Exchange in Adults Using Exclusively Albumin Replacement Fluid 2 Days After Percutaneous Kidney Biopsy |
| topic | Journal of Clinical Apheresis |
| url | https://onlinelibrary.wiley.com/doi/10.1002/jca.70122 |